Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.33	93.68	135.57	103.84	102.48	113.93
Short-Term Investments	-	2.24	0.31	0.87	-	-
Cash & Short-Term Investments	21.33	95.92	135.88	104.71	102.48	113.93
Cash Growth	-66.55%	-29.41%	29.77%	2.18%	-10.05%	35.00%
Receivables	92.69	217.45	109.86	82	89.45	82.46
Inventory	26.68	29.63	26.22	28.25	24.78	25.02
Prepaid Expenses	17.27	13	13.02	9.26	4.37	3.64
Restricted Cash	0.16	0.65	0.58	0.5	0.81	0.6
Other Current Assets	-	5.53	0.38	0.32	0.72	1.33
Total Current Assets	158.13	362.19	285.94	225.04	222.61	226.98
Property, Plant & Equipment	146.41	159.46	126.24	156.35	145.66	128.3
Goodwill	28.77	28.77	28.77	28.77	28.77	28.77
Other Intangible Assets	2.57	9.15	12.47	15.87	20.79	25.67
Long-Term Deferred Tax Assets	-	29.96	39.46	28	30.01	31.99
Long-Term Deferred Charges	-	-	-	-	-	1.22
Other Long-Term Assets	33.03	9.2	5.01	5.99	1.52	0.31
Total Assets	368.91	598.73	497.89	460.03	449.36	443.26

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	22.48	31.95	28.91	30.72	32.33	29.34
Accrued Expenses	15.86	44.41	31.22	21.36	20.43	30.32
Current Portion of Long-Term Debt	-	-	-	5.49	4.54	2.66
Current Portion of Leases	9.31	18.64	9.11	16.55	14.17	15.95
Current Income Taxes Payable	-	-	4.29	2.8	2.63	1.16
Current Unearned Revenue	-	3.86	-	-	-	-
Other Current Liabilities	-	1.26	3.95	3.59	0.93	3.28
Total Current Liabilities	47.65	100.12	77.48	80.51	75.02	82.71
Long-Term Debt	-	-	-	60.75	66.23	70.77
Long-Term Leases	55.2	63.5	34.2	38.9	41.31	46.89
Other Long-Term Liabilities	3.31	1.19	0.89	1.21	1.12	1.56
Total Liabilities	106.16	164.81	112.57	181.36	183.69	201.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	302.16	303.19	302.99	319.62	310.96	302.16
Retained Earnings	-182.44	-3.08	-40.11	-40.97	-45.3	-60.83
Total Common Equity	119.74	300.13	262.9	278.66	265.67	241.34
Shareholders' Equity	262.74	433.92	385.32	278.66	265.67	241.34
Total Liabilities & Equity	368.91	598.73	497.89	460.03	449.36	443.26

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	64.52	82.14	43.31	121.68	126.25	136.27
Net Cash (Debt)	-43.19	13.79	92.57	-16.97	-23.78	-22.34
Net Cash Growth	-	-85.11%	-	-	-	-
Net Cash Per Share	-0.34	0.11	0.70	-0.13	-0.18	-0.17
Filing Date Shares Outstanding	129.8	128.64	126.83	131.96	131.18	128.77
Total Common Shares Outstanding	129.79	126.95	125.73	131.32	130.92	128.68
Working Capital	110.48	262.06	208.46	144.54	147.59	144.27
Book Value Per Share	0.92	2.36	2.09	2.12	2.03	1.88
Tangible Book Value	88.39	262.21	221.66	234.02	216.11	186.89
Tangible Book Value Per Share	0.68	2.07	1.76	1.78	1.65	1.45
Buildings	-	-	13.6	4.94	4.94	4.94
Machinery	-	69.23	63.25	64.59	57.15	53.96
Construction In Progress	-	26.74	21.89	59.07	65.56	47.46
Leasehold Improvements	-	67.87	63.34	60.82	37.61	30.53

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error